NEW YORK (GenomeWeb News) – Investment firm ISI Group on Wednesday downgraded shares of Hologic, saying the company's new management will need time to turn the business around.

ISI downgraded Hologic's shares to Buy from a previous Strong Buy rating, but maintained earlier EPS estimates of $1.35 for Fiscal Year 2014; $1.55 for FY 2015; and $1.75 for FY 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.